LU90118B1 - Utilisation de la mélatonine dans le traitement des patients souffrant d'accoutumance à certaines drogues - Google Patents
Utilisation de la mélatonine dans le traitement des patients souffrant d'accoutumance à certaines drogues Download PDFInfo
- Publication number
- LU90118B1 LU90118B1 LU90118A LU90118A LU90118B1 LU 90118 B1 LU90118 B1 LU 90118B1 LU 90118 A LU90118 A LU 90118A LU 90118 A LU90118 A LU 90118A LU 90118 B1 LU90118 B1 LU 90118B1
- Authority
- LU
- Luxembourg
- Prior art keywords
- melatonin
- addiction
- patients
- treatment
- certain drugs
- Prior art date
Links
- 206010012335 Dependence Diseases 0.000 title 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 title 1
- 229960003987 melatonin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/381,535 US6469044B1 (en) | 1995-02-01 | 1995-02-01 | Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies |
| EP95303853A EP0724878B1 (en) | 1995-02-01 | 1995-06-06 | Use of melatonin for treating patients suffering from drug dependencies |
| PCT/IB1996/000082 WO1996023496A1 (en) | 1995-02-01 | 1996-01-29 | Use of melatonin for treating patients suffering from drug addiction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU90118B1 true LU90118B1 (fr) | 1997-11-13 |
Family
ID=26140195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU90118A LU90118B1 (fr) | 1995-02-01 | 1997-08-01 | Utilisation de la mélatonine dans le traitement des patients souffrant d'accoutumance à certaines drogues |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JP4516159B2 (ro) |
| CN (1) | CN1083263C (ro) |
| AT (1) | AT408188B (ro) |
| AU (1) | AU695366B2 (ro) |
| BG (1) | BG62876B1 (ro) |
| BR (1) | BR9607169A (ro) |
| CZ (1) | CZ291349B6 (ro) |
| DK (1) | DK176081B1 (ro) |
| EE (1) | EE03384B1 (ro) |
| FI (1) | FI119586B (ro) |
| IS (1) | IS1980B (ro) |
| LU (1) | LU90118B1 (ro) |
| LV (1) | LV11940B (ro) |
| MD (1) | MD1716C2 (ro) |
| NO (1) | NO312814B1 (ro) |
| NZ (1) | NZ298878A (ro) |
| PL (1) | PL183148B1 (ro) |
| SI (1) | SI9620022A (ro) |
| SK (1) | SK284521B6 (ro) |
| TR (1) | TR199700723T1 (ro) |
| TW (1) | TW483757B (ro) |
| WO (1) | WO1996023496A1 (ro) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1272177T3 (da) | 2000-01-05 | 2007-08-06 | Neurim Pharma 1991 | Fremgangsmåde og formulering til behandling af resistens over for antihypertensiva og forbundne tilstande |
| IL149377A (en) * | 2002-04-28 | 2012-10-31 | Neurim Pharma 1991 | Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds |
| IL155666A (en) | 2003-04-29 | 2013-12-31 | Neurim Pharma 1991 | Insomnia treatment |
| US9119846B2 (en) | 2003-04-29 | 2015-09-01 | Neurim Pharmaceuticals (1991) Ltd. | Method and composition for enhancing cognition in alzheimer's patients |
| US11918557B2 (en) | 2012-01-26 | 2024-03-05 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
| RU2631602C2 (ru) | 2012-01-26 | 2017-09-25 | Ванда Фармасьютиклз Инк. | Лечение нарушений циркадного ритма |
| KR20170058464A (ko) | 2012-12-18 | 2017-05-26 | 반다 파마슈티칼즈, 인코퍼레이티드. | 일주기 리듬 장애의 치료 |
| US11090285B2 (en) | 2013-11-12 | 2021-08-17 | Vanda Pharmaceuticals Inc | Treatment of circadian rhythm disorders |
| US10376487B2 (en) | 2013-11-12 | 2019-08-13 | Vanda Pharmaceuticals Inc. | Method of treatment |
| EP3337462B1 (en) * | 2016-10-31 | 2020-09-30 | Neurim Pharmaceuticals Ltd. | Melatonin mini-tablets and method of manufacturing the same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0518468T3 (da) * | 1991-05-09 | 2000-01-31 | Neurim Pharma 1991 | Melatoninholdige sammensætninger |
| IT1251544B (it) * | 1991-05-13 | 1995-05-17 | Gabriele Biella | Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico |
-
1996
- 1996-01-29 BR BR9607169A patent/BR9607169A/pt not_active Application Discontinuation
- 1996-01-29 PL PL96321630A patent/PL183148B1/pl unknown
- 1996-01-29 CN CN96191750A patent/CN1083263C/zh not_active Expired - Lifetime
- 1996-01-29 JP JP52338596A patent/JP4516159B2/ja not_active Expired - Lifetime
- 1996-01-29 AT AT0901396A patent/AT408188B/de not_active IP Right Cessation
- 1996-01-29 EE EE9700166A patent/EE03384B1/xx not_active IP Right Cessation
- 1996-01-29 MD MD97-0254A patent/MD1716C2/ro not_active IP Right Cessation
- 1996-01-29 CZ CZ19972405A patent/CZ291349B6/cs not_active IP Right Cessation
- 1996-01-29 NZ NZ298878A patent/NZ298878A/xx not_active IP Right Cessation
- 1996-01-29 WO PCT/IB1996/000082 patent/WO1996023496A1/en not_active Ceased
- 1996-01-29 SK SK1030-97A patent/SK284521B6/sk unknown
- 1996-01-29 SI SI9620022A patent/SI9620022A/sl not_active IP Right Cessation
- 1996-01-29 TR TR97/00723T patent/TR199700723T1/xx unknown
- 1996-01-29 AU AU44574/96A patent/AU695366B2/en not_active Expired
- 1996-04-12 TW TW085104319A patent/TW483757B/zh not_active IP Right Cessation
-
1997
- 1997-07-24 LV LVP-97-144A patent/LV11940B/en unknown
- 1997-07-25 IS IS4532A patent/IS1980B/is unknown
- 1997-07-30 BG BG101803A patent/BG62876B1/bg unknown
- 1997-07-30 DK DK199700896A patent/DK176081B1/da not_active IP Right Cessation
- 1997-07-31 FI FI973185A patent/FI119586B/fi not_active IP Right Cessation
- 1997-07-31 NO NO19973531A patent/NO312814B1/no not_active IP Right Cessation
- 1997-08-01 LU LU90118A patent/LU90118B1/fr active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2007001I1 (el) | Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη | |
| EP0963219A4 (en) | PROCESSING NITROSATIVE AND OXIDATIVE STRESS TO TREAT A DISEASE | |
| IT9083334A0 (it) | Procedimento per l'estrazione e la purificazione di dna genomico umano | |
| FI20000720L (fi) | Pitkitettyyn vapautumiseen perustuva tablettiformulaatio Parkisonin taudin hoitamiseksi | |
| HUP0104803A3 (en) | Process and system for the administration of medicine through the skin | |
| LU90118B1 (fr) | Utilisation de la mélatonine dans le traitement des patients souffrant d'accoutumance à certaines drogues | |
| EP0861082A4 (en) | Tissue Membrane Insufficiency Therapy | |
| EP0832204A4 (en) | TREATMENT OF INSULIN RESISTANCE | |
| FR2717080B1 (fr) | Utilisation de l'éliprodil et de ses énantiomères pour la préparation de médicaments utiles dans le traitement des neuropathies périphériques et des maladies neurodégénératives centrales. | |
| FI941345A7 (fi) | Retinoidit ja niiden käyttö ihosairauksien ja leukemian hoitoon | |
| FR2684552B1 (fr) | Utilisation de la d-fenfluramine et de derives de la fenfluramine dans le traitement de l'hypertension chez des sujets insulino-resistants. | |
| ZA952519B (en) | Therapeutic use of hemoglobin in the treatment of blood vessel blockage | |
| EP0990441A4 (en) | MEDICINES FOR TREATING DIABETIC NEPHROSIS | |
| EP0840605A4 (en) | COMPOUNDS FOR USE IN THE TREATMENT OF NEUROFIBROMATOSE | |
| FR2774596B1 (fr) | Utilisation de composes selenies dans la prevention et le traitement de la maladie d'alzheimer | |
| FR2744364B1 (fr) | Application d'ureidoacetamides a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif | |
| AU1413997A (en) | Use of rc-9 in diagnosis and treatment of proliferative arterial disease | |
| GB2284153B (en) | Substances for use in treatment of HIV-infection in HIV-infected patients | |
| GB9401745D0 (en) | Improvements in and relating to the administration of medicaments or therapeutic substances | |
| FI973259A0 (fi) | LCK-SH2-spesifisten yhdisteiden käyttö hoidettaessa autoimmuunisairauksia ja kudossiirrännäisten hyljintää | |
| FR2744363B1 (fr) | Application de derives de thiazolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif | |
| ID28817A (id) | Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri | |
| EP0651816A4 (en) | CONTENT OF CCK PEPTIDES IN FLOWER IN RELATION TO THE TREATMENT OF PANIC RIFLES. | |
| FR2702151B1 (fr) | Application d'anticonvulsivants dans le traitement du neuro-sida. | |
| GB9701919D0 (en) | Materials and methods relating to the diagnosis of susceptibility to HIV-1 infection and to treatment methods related to HIV-1 |